Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Don't be the captain and go down with this sinking ship...take the loss (tax write-off) while you still have a chance. I had a hard time getting my market order to go through a few days ago.
Indeed! Per the PR today... "The appointment of Mr. Schlossberg and Mr. Lapointe as independent members of the Company's Board of Directors enables ImmunoCellular to regain compliance with the listing standards of the New York Stock Exchange MKT regarding the majority of independent directors' requirement as well as having at least three independent directors serving on the Audit Committee."
Looking like consolidation taking place at .49, should surge up at end of the day just like Friday!!!
Can't wait for Thursday!!! : )
End of day volume was intense...sea of green. Next week should be interesting!!! Buying more on Monday when funds clear! GL longs!!!!
Here are some good links...
https://www.cirm.ca.gov/sites/default/files/files/agenda/150924_AGENDA_8_CTS1-08280%20Public%20Summary.pdf
The board almost never rejects a positive recommendation from its reviewers. (statement towards the bottom)
http://californiastemcellreport.blogspot.com/
CIRM Grant $19,919,449 in funds requested
https://www.cirm.ca.gov/node/33923/review
ImmunoCellular 2015 1Q Loss/Shr 2c --- beats by 3c
"During the first quarter, we strengthened our Company's financial standing, advanced ICT-107 toward our goal of initiating the phase 3 registration trial in newly diagnosed glioblastoma, continued to enroll patients in our ICT-121 phase 1 trial in recurrent glioblastoma, and moved forward with our novel Stem-to-T-cell program," said Andrew Gengos, ImmunoCellular's Chief Executive Officer. "We believe that we are on track to initiate the ICT-107 phase 3 trial in the late third quarter or fourth quarter of this year, following completion of the special protocol assessment process with the FDA and finalization of agreements with cancer cooperative groups and our contract research organization, which will manage the trial. Our ICT-121 phase 1 program is actively enrolling patients, and we are making good progress in starting our Stem-cell immunotherapy program which has potential advantages compared to engineered T-cell approaches to targeting and killing tumors. We believe that there is significant value in ImmunoCellular, given the breadth of our platforms and our preclinical and clinical assets, led by ICT-107. We are committed to advancing our programs with the goal of unlocking that value, and building a leading cancer immunotherapy company."
SMPP's Motto: "Think Local, Go Global"
Think Local = create a shell company to steal money
Go Global = travel the world at our expense
Hope everyone has a safe and happy Thanksgiving...I'm sure our wonderful CEO is having an extravagant Thanksgiving meal abroad while she travels the world.
IMUC due for reversal soon...? Technical chart gurus can you help me out and let me know what your thoughts are?!?
Recent News:
9/24/14 -- ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech
9/17/14 -- ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
IMUC due for reversal soon...? Technical chart gurus can you help me out and let me know what your thoughts are?!?
Recent News:
9/24/14 -- ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech
9/17/14 -- ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
IMUC due for reversal soon...? Technical chart gurus can you help me out and let me know what your thoughts are?!?
Recent News:
9/24/14 -- ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech
9/17/14 -- ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
IMUC reversal starting...check it out!?!
IMUC
Can you guys blast this please!!! Thanks!
IMUC due for reversal soon...? Technical chart gurus can you help me out and let me know what your thoughts are?!?
Recent News:
9/24/14 -- ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech
9/17/14 -- ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
IMUC due for reversal soon...? Technical chart gurus can you help me out and let me know what your thoughts are?!?
Recent News:
9/24/14 -- ImmunoCellular Therapeutics Expands Cancer Immunotherapy Platform with Antigen-Specific T-cell Technology Licensed from Caltech
9/17/14 -- ImmunoCellular Therapeutics Receives Positive Regulatory Feedback on ICT-107 Supporting Advancement to Registrational Phase III Testing in Newly Diagnosed Glioblastoma
Awesome, I didn't get to listen to the conference call yet.
I did like to see the two insider buys back in August 2014. They can join the red party with me (us) until IMUC takes off.
I was starting to think I was talking to myself, glad there is at least one other person at the party. : )
I have faith in IMUC Mgmt, but wish they would put out a PR to get rid of all of the nay sayers and show people there is some value in this stock...it's been bleeding since the end of May when it hit the 1.40's and now we are down into the .70's. I still have faith this will bounce back. Need some positive PR's to do that though.
Reversal coming soon IMO...look at the charts, especially the ADX. They are just toying with it now to see if they can knock it down further before the run up.
Damn should have waited 20 more minutes to grab some .77's...oh well. Can't time them all.
When they are done gutting the pig will there be any meat left?
Just added some more to my position. Time to hold, sit back and enjoy the ride for a while. Good luck longs.
Yea big joke...haha! Hoping one day I log into my TD account and see this bad boy in the green.
Remember when SMPP gave the 3% restricted stock dividend for the total shares you were holding? I still have those in my TD account too and they don't even have a ticker symbol associated with them. I call those my SMPP ghosties...worthless. Ha
http://www.otcmarkets.com/stock/SMPP/news?id=24819
It's been rather quiet on here lately...everyone close out of their positions or what? Curious what they are going to disclose on the earnings call tomorrow night. Picking some more shares up tomorrow once funds clear.
Added some more today to bring my price point down, glad I did.
Small cap biotechs are known for their volatility...look at the 3 year chart and you will see huge spikes up and down. I'm hurting too from this drop, but am playing this one for the long term. I am planning to add if this falls any further. GL longs. Tree shaking before the next run up, who knows?
I'm looking at this as a long term hold, just stop by from time to time to check where we are at in terms of pps. We have been trading sideways since February 2014, between ~1.05-1.40, with a couple of pops testing 1.50 and a couple of drops testing 1.05. I think once we have some substantial news about moving to Phase III or at least meetings held with FDA/EMA are announced this will creep back up and retest the 6 month highs. Just my opinion, looking to hold into early 2015 and re-evaluate from there. Plan to add more along the way when the pps falls on sharp down days when funds are available. Good luck! I'm optimistic this will have a huge up day before the end of the summer, I don't want to miss the run.
Stop-loss shakeout, almost back to open pps...time to move up?
Buy, hold and wait for the news...Rome wasn't built in a day. When we have a huge influx of volume to the upside we will start to fill the gap from the gap down back in December. I have a feeling a PR will be released in the next week or two with some positive sentiment IMO. Good luck longs.
Who in their right mind would sell at this level? It will work its way up when the big boys want it to...you will either be in or on the sidelines. I'm sure they will gap it up in pre-market the day they decide to run it up and the ones on the sidelines will have to pay the premium to get in for the ride.
Let's play GUESS THE PPS on July 15, 2014.
I'm predicting we are in the 1.80-1.90 range...any other takers?
Loading time before the run up
Wish I had more dry powder today...will have more funds available Monday. Hope we continue to trade sideways until Monday so I can add more at this level. Looks like a slow creep upward is in order. Accumulation is taking place...no point in selling this under $2, even if you have to hold it for a while.
I'm not really looking for short term play here so I don't know how this will play out in the next week or two. I'm waiting for the below (meetings with FDA and EMA) to happen and will continue to buy over the course of the next couple of months adding to my position on the down days.
"The Company is in the process of finalizing the design of the phase III protocol, in anticipation of discussions with the FDA and the European Medicines Agency, or EMA. Plans are underway to request an end-of-phase II meeting with the FDA, anticipated to take place during the summer. Following typical European protocol in preparation for meeting with the EMA, ImmunoCellular has requested advice meetings at the national level in Germany, the UK and the Netherlands to discuss ICT-107. These meetings are scheduled to take place later in June. In the third or fourth quarter of 2014, the Company plans to seek advice from the EMA on the approval process for ICT-107."
http://finance.yahoo.com/news/immunocellular-therapeutics-presents-updated-ict-113000537.html
Added to my position this morning at 1.17. Time to sit back and watch the show! : ) GL all longs.
Wow, disappointing day...all May gains erased in IMUC.
1.06 low??? Am I seeing things...pure manipulation going on.
Was pre-market (1.50's) smoke and mirrors to give individual investors some hope not to sell so the institutional slime could dump and move onto the next sector to rape, pillage and plunder?
Something seems a little bit shady to me, I'll continue to accumulate.
Shorts last ditch effort to take out stops before the move up? I'm holding for a while so doesn't bother me one bit. Good opportunity to add more.
Looks like the 2014 ASCO presentation went well...details at the link below:
http://finance.yahoo.com/news/immunocellular-therapeutics-presents-updated-ict-113000537.html
ImmunoCellular Therapeutics upgraded by Roth Capital to buy.
http://y.ahoo.it/FqFRBrHZ
ImmunoCellular Therapeuticss PT cut by Maxim Group to $4.00 buy rating.
http://y.ahoo.it/S4yTtzBf
Positive sentiment my friend, better cover your short position...
"We are honored that the ASCO Scientific Program Committee has selected our work in newly diagnosed GBM for oral presentation, typically reserved for important clinical and translational research findings," said Andrew Gengos, ImmunoCellular Chief Executive Officer. "We are looking forward to discussing the ICT-107 phase II results with key opinion leaders in the neuro-oncology community during, and in conjunction with, our presentation. We anticipate presenting updated overall survival results for both the whole trial population and key predefined sub-groups, as well as important immunological analyses that can provide insights relative to vaccine potency and response. This larger and richer data set will be the basis for informing our phase III design and execution strategies. We look forward to Dr. Wen's presentation, and want to express our sincere appreciation for the ongoing interest and support within the neuro-oncology community for ICT-107's continued development."
I'm in at 1.29... Patiently waiting for ASCO news and anything regarding meeting with FDA regarding phase III trial. I didn't catch the bottom but going to let my 7,500 shares ride. This will be $10 in a couple years or $0. Feel good with my chances. GL to you.
Lol didn't listen...when are you planning to jump in? Before/after earnings?